Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients

NCT05991089 | Completed

• 1 other identifier: DAC-014-TUNCKDH
• Study Type: observational
• Target: 11,770
• Locations: 1 country
• Sites: 1

Brief Summary

In Tunisia, high blood pressure (HTN) is a public health problem whose prevalence varies from 28.7% to 34.7%. Hypertension can be both, cause and consequence of chronic kidney disease, and its prevalence is quite high in this population. It is both a risk factor for mortality and cardiovascular morbidity, but also a major cause of terminal chronic kidney disease becoming an additional public health concern. Detecting and diagnosing chronic kidney in all hypertensives at an early stage remains a global public health challenge. A well-conducted treatment makes it possible to reach the blood pressure objective but also to reduce the risk of occurrence of a cardiovascular event and to slow the progression of chronic kidney disease. In Tunisia, few data exists concerning the prevalence of chronic kidney disease in hypertensive subjects, thus limiting the development and elaboration of preventive measures. A national survey will thus be conducted by the "Kidney and Metabolic Diseases" Working Group under the aegis of the Tunisian Society of Nephrology, Dialysis and Kidney Transplantation. The main objective is to estimate the prevalence of chronic kidney disease in hypertensive tunisian patients.

Conditions

Chronic Kidney Diseases; Hypertension

Outcome Measures

Primary Outcomes (1)

• Prevalence of Chronic Kidney Disease

  Frequency of hypertensive subjects with chronic kidney disease

  At inclusion

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All confirmed hypertensive patients at enrollment

You may qualify if:

• Confirmed Hypertension
• Follow-up at consultation at least for three months before enrollment date
• Informed consent

You may not qualify if:

• Hypertension emergency
• Pregnancy
• Kidney transplanted subjects
• Dialysis stage

Sponsors & Collaborators

• Dacima Consulting: lead
• Tunisian Society for Nephrology, Dialysis and Renal Transplantation: collaborator

Study Sites (1)

Tunisian Society for Nephrology, Dialysis and Renal Transplantation

Tunis, Tunisia, 1000, Tunisia

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic; Hypertension

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Jannet Labidi, MD

  Military Hospital of Tunis (Tunis, Tunisia)

  STUDY CHAIR

• Amel Harzallah, MD

  University Hospital of Charles Nicolle (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Awatef Azzabi, MD

  University Hospital of Sahloul (Sousse, Tunisia)

  PRINCIPAL INVESTIGATOR

• Badreddine Ben Kaab, MD

  La Marsa Internal Security Forces Hospital (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Ikram Mami, MD

  University Hospital of La Rabta (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Lamia Rais, MD

  University Hospital of La Rabta (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Maissa Hadji Brahim, MD

  University Hospital of Taher Sfar (Mahdia, Tunisia)

  PRINCIPAL INVESTIGATOR

• Mouna Hammouda, MD

  University Hospital of Fattouma Bourguiba (Monastir, Tunisia)

  PRINCIPAL INVESTIGATOR

• Sahar Agrebi, MD

  University Hospital of Charles Nicolle (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

• Seifeddine Azaiez, MD

  Private Clinic (Ben Arous, Tunisia)

  PRINCIPAL INVESTIGATOR

• Soumaya Chargui, MD

  University Hospital of Charles Nicolle (Tunis, Tunisia)

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 6, 2023
• First Posted: August 14, 2023
• Study Start: January 8, 2024
• Primary Completion: July 1, 2024
• Study Completion: July 1, 2024
• Last Updated: September 5, 2024

Record last verified: 2024-08

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)